nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure
|
Lee, Warren L |
|
|
11 |
9 |
p. 759-760 |
artikel |
2 |
Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management
|
Delcroix, Marion |
|
|
11 |
9 |
p. 836-850 |
artikel |
3 |
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
|
Winters, Nicholas |
|
|
11 |
9 |
p. 782-790 |
artikel |
4 |
Detecting hypoxaemia among children with pneumonia in low-resource settings
|
El Arifeen, Shams |
|
|
11 |
9 |
p. 756-757 |
artikel |
5 |
From profit to impact: lives saved and the future of RSV vaccine development
|
Mazur, Natalie |
|
|
11 |
9 |
p. 763-765 |
artikel |
6 |
Germany's cycling vision threatened by proposed budget cuts
|
Balakrishnan, Vijay Shankar |
|
|
11 |
9 |
p. 766 |
artikel |
7 |
HLA-B*15:01 allele and asymptomatic SARS-CoV-2 infection
|
Triunfol, Marcia |
|
|
11 |
9 |
p. e83 |
artikel |
8 |
Holding out for a hero
|
Ranscombe, Peter |
|
|
11 |
9 |
p. 768 |
artikel |
9 |
Illuminating the many faces of pulmonary hypertension
|
Newman, Joseph |
|
|
11 |
9 |
p. 760-762 |
artikel |
10 |
Influenza deaths for the 2022–23 season
|
Venkatesan, Priya |
|
|
11 |
9 |
p. e82 |
artikel |
11 |
Inhibiting C5 in patients with severe COVID-19—the incorrect target?
|
Lim, Endry H T |
|
|
11 |
9 |
p. e80 |
artikel |
12 |
Inhibiting C5 in patients with severe COVID-19—the incorrect target? – Authors’ reply
|
Annane, Djillali |
|
|
11 |
9 |
p. e81 |
artikel |
13 |
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
|
Brown, Samuel M |
|
|
11 |
9 |
p. 791-803 |
artikel |
14 |
Natalie Mazur—creating an affordable vaccine for RSV
|
Kirby, Tony |
|
|
11 |
9 |
p. 767 |
artikel |
15 |
New developments in bronchiectasis
|
The Lancet Respiratory Medicine, |
|
|
11 |
9 |
p. 755 |
artikel |
16 |
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management
|
Olsson, Karen M |
|
|
11 |
9 |
p. 820-835 |
artikel |
17 |
Reducing treatment burden in the era of CFTR modulators
|
Robinson, Paul D |
|
|
11 |
9 |
p. e78 |
artikel |
18 |
Reducing treatment burden in the era of CFTR modulators – Authors' reply
|
Gifford, Alex H |
|
|
11 |
9 |
p. e79 |
artikel |
19 |
Risk and accuracy of outpatient-identified hypoxaemia for death among suspected child pneumonia cases in rural Bangladesh: a multifacility prospective cohort study
|
McCollum, Eric D |
|
|
11 |
9 |
p. 769-781 |
artikel |
20 |
Shorter regimens for tuberculosis preventive treatment: piecing together the global implementation jigsaw
|
van Crevel, Reinout |
|
|
11 |
9 |
p. 757-759 |
artikel |
21 |
Treatment of pulmonary arterial hypertension: recent progress and a look to the future
|
Humbert, Marc |
|
|
11 |
9 |
p. 804-819 |
artikel |